Dynamic hyperinflation and intrinsic positive end-expiratory pressure in ARDS patients.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
27 Nov 2019
Historique:
received: 01 05 2019
accepted: 13 09 2019
entrez: 29 11 2019
pubmed: 30 11 2019
medline: 6 5 2020
Statut: epublish

Résumé

In ARDS patients, changes in respiratory mechanical properties and ventilatory settings can cause incomplete lung deflation at end-expiration. Both can promote dynamic hyperinflation and intrinsic positive end-expiratory pressure (PEEP). The aim of this study was to investigate, in a large population of ARDS patients, the presence of intrinsic PEEP, possible associated factors (patients' characteristics and ventilator settings), and the effects of two different external PEEP levels on the intrinsic PEEP. We made a secondary analysis of published data. Patients were ventilated with a tidal volume of 6-8 mL/kg of predicted body weight, sedated, and paralyzed. After a recruitment maneuver, a PEEP trial was run at 5 and 15 cmH We enrolled 217 sedated, paralyzed patients: 87 (40%) had intrinsic PEEP with a median of 1.1 [1.0-2.3] cmH In sedated, paralyzed ARDS patients without a known obstructive disease, the amount of intrinsic PEEP during lung-protective ventilation is negligible and does not influence respiratory mechanical properties.

Sections du résumé

BACKGROUND BACKGROUND
In ARDS patients, changes in respiratory mechanical properties and ventilatory settings can cause incomplete lung deflation at end-expiration. Both can promote dynamic hyperinflation and intrinsic positive end-expiratory pressure (PEEP). The aim of this study was to investigate, in a large population of ARDS patients, the presence of intrinsic PEEP, possible associated factors (patients' characteristics and ventilator settings), and the effects of two different external PEEP levels on the intrinsic PEEP.
METHODS METHODS
We made a secondary analysis of published data. Patients were ventilated with a tidal volume of 6-8 mL/kg of predicted body weight, sedated, and paralyzed. After a recruitment maneuver, a PEEP trial was run at 5 and 15 cmH
RESULTS RESULTS
We enrolled 217 sedated, paralyzed patients: 87 (40%) had intrinsic PEEP with a median of 1.1 [1.0-2.3] cmH
CONCLUSIONS CONCLUSIONS
In sedated, paralyzed ARDS patients without a known obstructive disease, the amount of intrinsic PEEP during lung-protective ventilation is negligible and does not influence respiratory mechanical properties.

Identifiants

pubmed: 31775830
doi: 10.1186/s13054-019-2611-6
pii: 10.1186/s13054-019-2611-6
pmc: PMC6880369
doi:

Substances chimiques

Intrinsic Factor 9008-12-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

375

Commentaires et corrections

Type : CommentIn

Références

J Appl Physiol. 1966 Nov;21(6):1913-7
pubmed: 4380914
Crit Care Med. 2013 Apr;41(4):935-44
pubmed: 23385101
Am J Respir Crit Care Med. 1995 Aug;152(2):531-7
pubmed: 7633703
Am Rev Respir Dis. 1987 Oct;136(4):872-9
pubmed: 3662241
Am J Respir Crit Care Med. 2014 Mar 1;189(5):520-31
pubmed: 24467647
Am Rev Respir Dis. 1985 Mar;131(3):414-20
pubmed: 3977179
Am J Respir Crit Care Med. 2018 Jul 1;198(1):131-134
pubmed: 29466674
Eur Respir J. 2016 Jan;47(1):233-42
pubmed: 26493798
Crit Care Med. 2002 Jul;30(7):1407-12
pubmed: 12130953
Am Rev Respir Dis. 1985 May;131(5):672-7
pubmed: 4003913
Intensive Care Med. 2017 May;43(5):603-611
pubmed: 28283699
Am Rev Respir Dis. 1988 Aug;138(2):355-61
pubmed: 3195835
Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1726-34
pubmed: 8970362
N Engl J Med. 2006 Apr 27;354(17):1775-86
pubmed: 16641394
J Appl Physiol. 1975 Jul;39(1):60-5
pubmed: 1150593
Am Rev Respir Dis. 1989 Jul;140(1):1-3
pubmed: 2665582
Anesthesiology. 2019 Jul;131(1):58-73
pubmed: 30882475
Am J Respir Crit Care Med. 1995 Jun;151(6):1807-14
pubmed: 7767524
Chest. 2018 Oct;154(4):948-962
pubmed: 29432712
Ann Intensive Care. 2016 Dec;6(1):53
pubmed: 27306887
Crit Care Med. 2014 Feb;42(2):252-64
pubmed: 24196193
Intensive Care Med. 2012 Oct;38(10):1573-82
pubmed: 22926653
Intensive Care Med. 2002 Aug;28(8):1078-83
pubmed: 12185428
Am J Respir Crit Care Med. 2018 Jan 1;197(1):132-136
pubmed: 28557528
Am J Respir Crit Care Med. 2016 Jun 1;193(11):1254-63
pubmed: 26699672
Am J Respir Crit Care Med. 2010 Mar 15;181(6):578-86
pubmed: 19910610
J Appl Physiol (1985). 1998 Oct;85(4):1236-43
pubmed: 9760311
Crit Care Med. 2002 Sep;30(9):1941-9
pubmed: 12352025
Acta Anaesthesiol Scand. 2004 Oct;48(9):1080-8
pubmed: 15352952
J Appl Physiol (1985). 1997 Mar;82(3):723-31
pubmed: 9074955
Am J Respir Crit Care Med. 2000 May;161(5):1590-6
pubmed: 10806160
Am J Respir Crit Care Med. 2011 Oct 1;184(7):756-62
pubmed: 21700908
N Engl J Med. 1975 Feb 6;292(6):284-9
pubmed: 234174
Am Rev Respir Dis. 1982 Jul;126(1):166-70
pubmed: 7046541
Clin Chest Med. 1996 Sep;17(3):379-94
pubmed: 8875002
Intensive Care Med. 2019 Feb;45(2):290-291
pubmed: 30560279
Am J Respir Crit Care Med. 2001 Nov 1;164(9):1701-11
pubmed: 11719313
Crit Care. 2017 Sep 12;21(1):240
pubmed: 28899408
Crit Care Med. 2018 Nov;46(11):1761-1768
pubmed: 30048331
Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 1):1311-7
pubmed: 7952558
Am Rev Respir Dis. 1993 Jan;147(1):14-24
pubmed: 8420408
Anesthesiology. 1972 Dec;37(6):626-33
pubmed: 4652779
Anesth Analg. 2017 Feb;124(2):524-530
pubmed: 27537927
Eur Respir J Suppl. 2003 Aug;42:43s-47s
pubmed: 12946000
Am J Respir Crit Care Med. 2002 May 1;165(9):1271-4
pubmed: 11991877
Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):544-51
pubmed: 1892293
Intensive Care Med. 2004 Jul;30(7):1311-8
pubmed: 15054570

Auteurs

Silvia Coppola (S)

Department of Anesthesia and Intensive Care, ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy.

Alessio Caccioppola (A)

Department of Health Sciences, University of Milan, Milan, Italy.

Sara Froio (S)

Department of Anesthesia and Intensive Care, ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy.

Erica Ferrari (E)

Department of Health Sciences, University of Milan, Milan, Italy.

Miriam Gotti (M)

Department of Anesthesia and Intensive Care, ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy.

Paolo Formenti (P)

Department of Anesthesia and Intensive Care, ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy.

Davide Chiumello (D)

Department of Anesthesia and Intensive Care, ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy. chiumello@libero.it.
Department of Health Sciences, University of Milan, Milan, Italy. chiumello@libero.it.
Coordinated Research Center on Respiratory Failure, University of Milan, Milan, Italy. chiumello@libero.it.
SC Anestesia e Rianimazione, ASST Santi Paolo e Carlo, Via Di Rudinì, Milan, Italy. chiumello@libero.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH